MEI Pharma (MEIP) Short Interest Ratio & Short Volume $2.29 +0.03 (+1.33%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.29 0.00 (0.00%) As of 06/13/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEI Pharma Short Interest DataMEI Pharma (MEIP) has a short interest of 2,700 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a 42.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 43,402 shares to cover all short positions.Current Short Interest2,700 sharesPrevious Short Interest1,900 sharesChange Vs. Previous Month+42.11%Dollar Volume Sold Short$6.02 thousandShort Interest Ratio0.3 Days to CoverLast Record DateMay 31, 2025Outstanding Shares6,660,000 sharesFloat Size6,580,000 sharesShort Percent of Float0.04%Today's Trading Volume5,252 sharesAverage Trading Volume43,402 sharesToday's Volume Vs. Average12% Short Selling MEI Pharma? Sign up to receive the latest short interest report for MEI Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEIP Short Interest Over TimeMEIP Days to Cover Over TimeMEIP Percentage of Float Shorted Over Time MEI Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20252,700 shares $6.02 thousand +42.1%0.0%0.3 $2.23 5/15/20251,900 shares $4.05 thousand No Change0.0%0.2 $2.13 4/30/20251,900 shares $3.88 thousand -59.6%0.0%0.2 $2.04 4/15/20254,700 shares $9.59 thousand +80.8%0.1%0.5 $2.04 3/31/20252,600 shares $5.69 thousand -25.7%0.0%0.3 $2.19 3/15/20253,500 shares $8.16 thousand -39.7%0.1%0.2 $2.33 2/28/20255,800 shares $14.85 thousand +38.1%0.1%0.3 $2.56 2/15/20254,200 shares $11.30 thousand -27.6%0.1%0.2 $2.69 1/31/20255,800 shares $16.53 thousand -39.0%0.1%0.3 $2.85 1/15/20259,500 shares $26.32 thousand -27.5%0.1%0.2 $2.77 Get the Latest News and Ratings for MEIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/202413,100 shares $32.23 thousand -60.5%0.2%0.3 $2.46 12/15/202433,200 shares $89.64 thousand -32.1%0.5%0.7 $2.70 11/30/202448,900 shares $137.90 thousand -23.0%0.7%1.1 $2.82 11/15/202463,500 shares $185.42 thousand -21.6%1.0%1.5 $2.92 10/31/202481,000 shares $251.10 thousand +504.5%1.2%1.9 $3.10 10/15/202413,400 shares $36.31 thousand -30.9%0.2%0.7 $2.71 9/30/202419,400 shares $55.29 thousand +19.0%0.3%0.2 $2.85 9/15/202416,300 shares $49.39 thousand +45.5%0.3%0.2 $3.03 8/31/202411,200 shares $34.72 thousand -30.4%0.2%0.1 $3.10 8/15/202416,100 shares $51.04 thousand -66.9%0.3%0.2 $3.17 7/31/202448,600 shares $180.31 thousand +636.4%0.8%0.5 $3.71 7/15/20246,600 shares $18.78 thousand -62.7%0.1%0.1 $2.85 6/30/202417,700 shares $51.51 thousand +22.1%0.3%1 $2.91 6/15/202414,500 shares $42.05 thousand +7.4%0.2%0.8 $2.90 5/31/202413,500 shares $38.61 thousand -55.7%0.2%0.6 $2.86 5/15/202430,500 shares $94.70 thousand +33.8%0.5%1.5 $3.11 4/30/202422,800 shares $69.54 thousand +9.1%0.4%1.1 $3.05 4/15/202420,900 shares $67.93 thousand +168.0%0.3%1 $3.25 3/31/20247,800 shares $31.20 thousand -14.3%0.1%0.3 $4.00 3/15/20249,100 shares $34.85 thousand -27.2%0.2%0.4 $3.83 2/29/202412,500 shares $51.88 thousand +23.8%0.2%0.4 $4.15 2/15/202410,100 shares $46.16 thousand -97.0%0.2%0.3 $4.57 1/31/2024331,500 shares $1.49 million -1.1%5.4%7 $4.50 1/15/2024335,200 shares $1.94 million -0.7%5.5%6.7 $5.80 12/31/2023337,500 shares $1.96 million -7.5%5.5%6.9 $5.80 12/15/2023365,000 shares $2.31 million -5.7%5.9%7.1 $6.33 11/30/2023386,900 shares $2.38 million -2.8%6.3%6.6 $6.14 11/15/2023398,100 shares $3.12 million -25.7%6.5%7.4 $7.84 10/31/2023536,100 shares $3.66 million +7.4%8.9%13 $6.82 10/15/2023499,000 shares $3.34 million +18.8%8.2%12.4 $6.70The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 9/30/2023419,900 shares $2.94 million +57.3%6.9%9.1 $7.01 9/15/2023267,000 shares $1.38 million +3.6%4.4%6.1 $5.18 8/31/2023257,700 shares $1.37 million -29.8%4.3%7 $5.32 8/15/2023367,300 shares $2.57 million +16.0%6.1%7.9 $7.00 7/31/2023316,700 shares $2.24 million +1.1%5.2%5.7 $7.07 7/15/2023313,200 shares $2.33 million -4.7%5.2%4.8 $7.44 6/30/2023328,700 shares $2.16 million +2.3%5.4%5.1 $6.58 6/15/2023321,300 shares $2.37 million +5.6%5.3%4.8 $7.38 5/31/2023304,400 shares $2.34 million +28.4%5.0%4.2 $7.70 5/15/2023237,100 shares $1.69 million -14.7%3.9%2.9 $7.11 4/30/2023277,900 shares $1.41 million +17.7%4.6%3.8 $5.09 4/15/2023236,100 shares $1.13 million -95.6%3.9%3.9 $4.80 3/31/20235,340,000 shares $1.22 million +1.3%N/A5 $0.23 3/15/20235,270,000 shares $1.32 million +20.9%N/A4.7 $0.25 2/28/20234,360,000 shares $968.79 thousand +0.9%N/A3 $0.22 2/15/20234,320,000 shares $1.31 million +24.1%N/A3.2 $0.30 1/31/20233,480,000 shares $992.50 thousand -23.7%N/A2.8 $0.29 1/15/20234,560,000 shares $1.49 million +19.4%N/A3.6 $0.33 12/30/20223,820,000 shares $930.55 thousand +11.7%N/A3 $0.24 12/15/20223,420,000 shares $837.90 thousand -25.3%N/A2.7 $0.25 11/30/20224,580,000 shares $1.56 million +4.8%N/A3.9 $0.34 11/15/20224,370,000 shares $1.51 million -13.3%N/A5.9 $0.34 10/31/20225,040,000 shares $1.71 million +2.7%N/A6.8 $0.34 10/15/20224,910,000 shares $1.85 million +4.9%N/A6.1 $0.38 9/30/20224,680,000 shares $1.81 million +0.7%N/A5.1 $0.39 9/15/20224,650,000 shares $2.32 million -0.6%N/A2.9 $0.50 8/31/20224,680,000 shares $2.37 million -7.9%N/A2.1 $0.51 8/15/20225,080,000 shares $2.94 million -9.1%N/A1.6 $0.58 7/31/20225,590,000 shares $2.71 million -3.6%N/A1.6 $0.48 7/15/20225,800,000 shares $3.31 million -19.1%N/A1.3 $0.57 6/30/20227,170,000 shares $4.34 million -21.4%N/A1.3 $0.61 6/15/20229,120,000 shares $4.50 million -12.6%15.5%1.2 $0.49 5/31/202210,430,000 shares $4.96 million No ChangeN/A1.5 $0.48 5/15/202210,430,000 shares $5.40 million -3.9%N/A1.8 $0.52 4/30/202210,850,000 shares $5.34 million +23.0%10.0%1.9 $0.49 4/15/20228,820,000 shares $5.01 million +33.2%8.1%1.7 $0.57 3/31/20226,620,000 shares $3.99 million -10.3%6.1%1.9 $0.60 3/15/20227,380,000 shares $12.55 million +1.0%6.8%7.7 $1.70 2/28/20227,310,000 shares $15.79 million +10.8%6.7%6.8 $2.16 2/15/20226,600,000 shares $14.26 million +1.1%6.1%3.7 $2.16 1/31/20226,530,000 shares $12.60 million -8.5%6.0%3.9 $1.93 1/15/20227,140,000 shares $17.78 million +8.0%6.4%4.7 $2.49 12/31/20216,610,000 shares $17.65 million -5.4%6.2%4.5 $2.67 12/15/20216,990,000 shares $16.99 million -20.1%6.5%4.8 $2.43 11/30/20218,750,000 shares $29.49 million -1.8%8.3%6.9 $3.37 11/15/20218,910,000 shares $27.89 million +1.0%9.8%18.7 $3.13 10/29/20218,820,000 shares $24.87 million -1.5%8.5%20.6 $2.82 10/15/20218,950,000 shares $26.04 million -2.4%8.7%20.4 $2.91 9/30/20219,170,000 shares $25.31 million -4.5%8.9%21.4 $2.76 9/15/20219,600,000 shares $26.11 million +0.3%9.3%22.6 $2.72Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 8/31/20219,570,000 shares $26.80 million +0.2%9.3%21 $2.80 8/13/20219,550,000 shares $26.26 million +5.3%9.2%21 $2.75 7/30/20219,070,000 shares $24.49 million -5.0%8.8%16.3 $2.70 7/15/20219,550,000 shares $25.21 million -1.6%9.5%16.8 $2.64 6/30/20219,700,000 shares $27.65 million -15.1%9.6%16.3 $2.85 6/15/202111,420,000 shares $35.29 million +3.3%11.3%18.2 $3.09 5/28/202111,060,000 shares $31.85 million -1.3%11.0%17.3 $2.88 5/14/202111,200,000 shares $29.06 million -0.7%N/A16.2 $2.60 4/30/202111,280,000 shares $40.04 million +2.0%N/A13.3 $3.55 4/15/202111,060,000 shares $39.82 million +4.5%N/A11.6 $3.60 3/31/202110,580,000 shares $35.02 million +9.0%N/A10.8 $3.31 3/15/20219,710,000 shares $37.19 million -0.3%N/A9.2 $3.83 2/26/20219,740,000 shares $36.04 million +14.7%N/A9.5 $3.70 2/12/20218,490,000 shares $35.23 million +7.2%N/A8.6 $4.15 1/29/20217,920,000 shares $25.03 million +1.5%N/A8.8 $3.16 1/15/20217,800,000 shares $22.39 million No ChangeN/A10.9 $2.87 12/31/20207,800,000 shares $20.98 million +8.6%N/A11.2 $2.69 12/15/20207,180,000 shares $20.79 million +2.7%N/A11.8 $2.90 11/30/20206,990,000 shares $21.11 million -5.8%N/A10.2 $3.02 11/15/20207,420,000 shares $21.59 million -4.0%N/A10.1 $2.91 10/30/20207,730,000 shares $20.56 million +15.7%N/A9.7 $2.66 10/15/20206,680,000 shares $20.51 million +1.2%N/A7.4 $3.07 9/30/20206,600,000 shares $20.59 million -1.2%N/A6.4 $3.12 9/15/20206,680,000 shares $21.24 million +0.6%N/A4.8 $3.18 8/31/20206,640,000 shares $18.06 million +2.6%N/A4.3 $2.72 8/14/20206,470,000 shares $18.12 million +10.8%N/A3.7 $2.80 7/31/20205,840,000 shares $16.24 million -2.0%N/A3.1 $2.78 7/15/20205,960,000 shares $20.20 million -7.0%N/A3.1 $3.39 6/30/20206,410,000 shares $26.47 million +24.2%N/A2.4 $4.13 6/15/20205,160,000 shares $19.14 million +20.0%N/A2.2 $3.71 MEIP Short Interest - Frequently Asked Questions What is MEI Pharma's current short interest? Short interest is the volume of MEI Pharma shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 2,700 shares of MEIP short. 0.04% of MEI Pharma's shares are currently sold short. Learn More on MEI Pharma's current short interest. What is a good short interest percentage for MEI Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of MEI Pharma's floating shares are currently sold short. Is MEI Pharma's short interest increasing or decreasing? MEI Pharma saw a increase in short interest in May. As of May 31st, there was short interest totaling 2,700 shares, an increase of 42.1% from the previous total of 1,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MEI Pharma's float size? MEI Pharma currently has issued a total of 6,660,000 shares. Some of MEI Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MEI Pharma currently has a public float of 6,580,000 shares. How does MEI Pharma's short interest compare to its competitors? 0.04% of MEI Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MEI Pharma: Repare Therapeutics Inc. (1.83%), Biomea Fusion, Inc. (31.59%), Forte Biosciences, Inc. (3.25%), Clearside Biomedical, Inc. (0.18%), Gain Therapeutics, Inc. (1.02%), Precision BioSciences, Inc. (19.23%), InflaRx (2.26%), vTv Therapeutics Inc. (1.26%), Werewolf Therapeutics, Inc. (6.25%), Celularity Inc. (10.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short MEI Pharma stock? Short selling MEIP is an investing strategy that aims to generate trading profit from MEI Pharma as its price is falling. MEIP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MEI Pharma? A short squeeze for MEI Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEIP, which in turn drives the price of the stock up even further. How often is MEI Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEIP, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies RPTX Short Squeeze BMEA Short Squeeze FBRX Short Squeeze CLSD Short Squeeze GANX Short Squeeze DTIL Short Squeeze IFRX Short Squeeze VTVT Short Squeeze HOWL Short Squeeze CELU Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MEIP) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEI Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
